Ryan D. Maynard
2006
In 2006, Ryan D. Maynard earned a total compensation of $774.1K as Vice President, Chief Financial Officer at Rigel Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $68,186 |
|---|---|
| Option Awards | $485,959 |
| Salary | $219,583 |
| Other | $420 |
| Total | $774,148 |
Maynard received $486K in option awards, accounting for 63% of the total pay in 2006.
Maynard also received $68.2K in non-equity incentive plan, $219.6K in salary and $420 in other compensation.
Rankings
In 2006, Ryan D. Maynard's compensation ranked 3,663rd out of 7,022 executives tracked by ExecPay. In other words, Maynard earned more than 47.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,663 out of 7,022 | 48th |
Division Manufacturing | 1,189 out of 2,413 | 51st |
Major group Chemicals And Allied Products | 279 out of 673 | 59th |
Industry group Drugs | 179 out of 518 | 65th |
Industry Pharmaceutical Preparations | 140 out of 355 | 61st |
Source: SEC filing on April 15, 2009.
Maynard's colleagues
We found five more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2006.
2006
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2006
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2006
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2006
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2006
James Welch
Rigel Pharmaceuticals